Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-018200
Filing Date
2025-06-25
Accepted
2025-06-25 17:15:06
Documents
1
Period of Report
2025-06-23

Document Format Files

Seq Description Document Type Size
1 form4-06252025_050601.html 4  
1 form4-06252025_050601.xml 4 4241
  Complete submission text file 0001415889-25-018200.txt   5889
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Singh Shawn (Reporting) CIK: 0001412071 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37761 | Film No.: 251074474